GlnRS Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of GlnRS monoclonal antibodies for research on glutamyl-tRNA synthetase (GlnRS). GlnRS Antibodies are optimized for various techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glutamyl-tRNA synthetase plays a crucial role in protein synthesis by catalyzing the attachment of glutamic acid to its corresponding tRNA, ensuring the accurate translation of genetic information into functional proteins. The enzyme maintains essential cellular metabolism functions and influences various physiological processes, making it a significant target for research in cellular biology and disease mechanisms. Understanding GlnRS function and regulation can provide insights into disorders related to protein synthesis and amino acid metabolism. Researchers worldwide rely on GlnRS detection methods to explore cellular mechanisms and potential therapeutic approaches. Current investigations focus on how GlnRS influences cellular health and disease progression. Ongoing research continues to reveal new aspects of GlnRS biology and its impact on human health. Santa Cruz Biotechnology monoclonal antibodies for GlnRS support researchers in advancing scientific understanding of protein synthesis and cellular regulation.